A new study reveals that individuals with allergic rhinitis and asthma have distinct nasal fungal profiles, hinting at ...
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
Allergic rhinitis is a very common condition often termed as hay fever, which affects millions of people globally. This ...
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...
Thousands of people with a severe dust mite allergy could benefit from a "life changing" new daily treatment. The National ...
The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...
A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...
Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...
The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...